Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Dicker

Showing results (181-190 of 375) with videos related to

Pageof 38
Sort By:
International Journal of Radiation Oncology, Biology, Physics|January 1, 1997
The effect of treatment positioning on normal tissue dose in patients with prostate cancer treated with three-dimensional conformal radiotherapyM J Zelefsky, L Happersett, S A Leibel, et al.
Future Oncology (London, England)|July 11, 2013
Selectively starving cancer cells through dietary manipulation: methods and clinical implicationsBrittany A Simone, Colin E Champ, Anne L Rosenberg, et al.
American Journal of Clinical Oncology|June 21, 2016
The Missing Pieces in Reporting of Randomized Controlled Trials of External Beam Radiation Therapy Dose Escalation for Prostate CancerNicholas G Zaorsky, Brian L Egleston, Eric M Horwitz, et al.
American Journal of Clinical Oncology|July 9, 2016
Phase I Trial Using Induction Ciplatin, Docetaxel, 5-FU and Erlotinib Followed by Cisplatin, Bevacizumab and Erlotinib With Concurrent Radiotherapy for Advanced Head and Neck CancerPeter H Ahn, Mitchell Machtay, Pramila R Anne, et al.
International Journal of Radiation Oncology, Biology, Physics|November 7, 2006
A Phase II study of acute toxicity for Celebrex (celecoxib) and chemoradiation in patients with locally advanced cervical cancer: primary endpoint analysis of RTOG 0128David K Gaffney, Kathryn Winter, Adam P Dicker, et al.
Journal of Thrombosis and Haemostasis : JTH|August 22, 2009
Reducing intra-individual variation in platelet aggregation: implications for platelet function testingA J Peace, K Egan, G F Kavanagh, et al.
Molecular Psychiatry|July 23, 2014
Proteomic and genomic evidence implicates the postsynaptic density in schizophreniaM Föcking, L M Lopez, J A English, et al.
International Journal of Radiation Oncology, Biology, Physics|May 29, 2012
Implanted dosimeters identify radiation overdoses during IMRT for prostate cancerRobert B Den, Kamila Nowak, Ivan Buzurovic, et al.
Radiation Oncology (London, England)|April 27, 2013
Vascular endothelial growth factor (VEGF) expression in locally advanced prostate cancer: secondary analysis of radiation therapy oncology group (RTOG) 8610Larry Pan, Seunghee Baek, Pamela R Edmonds, et al.
Journal of Contemporary Brachytherapy|January 25, 2013
Re-implantation of suboptimal prostate seed implantation: technique with intraoperative treatment planningLaura Doyle, Adam J Hesney, Katherine L Chapman, et al.
Pageof 38

Showing results (181-190 of 375) with videos related to

Sort By:
Pageof 38
International Journal of Radiation Oncology, Biology, Physics|January 1, 1997
The effect of treatment positioning on normal tissue dose in patients with prostate cancer treated with three-dimensional conformal radiotherapyM J Zelefsky, L Happersett, S A Leibel, et al.
Future Oncology (London, England)|July 11, 2013
Selectively starving cancer cells through dietary manipulation: methods and clinical implicationsBrittany A Simone, Colin E Champ, Anne L Rosenberg, et al.
American Journal of Clinical Oncology|June 21, 2016
The Missing Pieces in Reporting of Randomized Controlled Trials of External Beam Radiation Therapy Dose Escalation for Prostate CancerNicholas G Zaorsky, Brian L Egleston, Eric M Horwitz, et al.
American Journal of Clinical Oncology|July 9, 2016
Phase I Trial Using Induction Ciplatin, Docetaxel, 5-FU and Erlotinib Followed by Cisplatin, Bevacizumab and Erlotinib With Concurrent Radiotherapy for Advanced Head and Neck CancerPeter H Ahn, Mitchell Machtay, Pramila R Anne, et al.
International Journal of Radiation Oncology, Biology, Physics|November 7, 2006
A Phase II study of acute toxicity for Celebrex (celecoxib) and chemoradiation in patients with locally advanced cervical cancer: primary endpoint analysis of RTOG 0128David K Gaffney, Kathryn Winter, Adam P Dicker, et al.
Journal of Thrombosis and Haemostasis : JTH|August 22, 2009
Reducing intra-individual variation in platelet aggregation: implications for platelet function testingA J Peace, K Egan, G F Kavanagh, et al.
Molecular Psychiatry|July 23, 2014
Proteomic and genomic evidence implicates the postsynaptic density in schizophreniaM Föcking, L M Lopez, J A English, et al.
International Journal of Radiation Oncology, Biology, Physics|May 29, 2012
Implanted dosimeters identify radiation overdoses during IMRT for prostate cancerRobert B Den, Kamila Nowak, Ivan Buzurovic, et al.
Radiation Oncology (London, England)|April 27, 2013
Vascular endothelial growth factor (VEGF) expression in locally advanced prostate cancer: secondary analysis of radiation therapy oncology group (RTOG) 8610Larry Pan, Seunghee Baek, Pamela R Edmonds, et al.
Journal of Contemporary Brachytherapy|January 25, 2013
Re-implantation of suboptimal prostate seed implantation: technique with intraoperative treatment planningLaura Doyle, Adam J Hesney, Katherine L Chapman, et al.
Pageof 38